• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从海洋无脊椎动物提取物文库中鉴定抗分枝杆菌天然产物。

Identification of Antimycobacterial Natural Products from a Library of Marine Invertebrate Extracts.

作者信息

Acquah Kojo Sekyi, Beukes Denzil R, Seldon Ronnett, Jordaan Audrey, Sunassee Suthananda N, Warner Digby F, Gammon David W

机构信息

Department of Chemistry, University of Cape Town, Cape Town 7701, South Africa.

School of Pharmacy, University of the Western Cape, Bellville 7535, South Africa.

出版信息

Medicines (Basel). 2022 Jan 28;9(2):9. doi: 10.3390/medicines9020009.

DOI:10.3390/medicines9020009
PMID:35200753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8880526/
Abstract

Tuberculosis (TB) remains a public health crisis, requiring the urgent identification of new anti-mycobacterial drugs. We screened several organic and aqueous marine invertebrate extracts for their in vitro inhibitory activity against the causative organism, . Here, we report the results obtained for 54 marine invertebrate extracts. The chemical components of two of the extracts were dereplicated, using H NMR and HR-LCMS with GNPS molecular networking, and these extracts were further subjected to an activity-guided isolation process to purify the bioactive components. yielded heteronemin and was found to produce the bengamide class of compounds, of which bengamides P and Q were isolated, while a new derivative, bengamide S , was putatively identified and its structure predicted, based on the similarity of its MS/MS fragmentation pattern to those of other bengamides. The isolated bioactive metabolites and semi-pure fractions exhibited growth inhibitory activity, in the range <0.24 to 62.50 µg/mL. This study establishes the bengamides as potent antitubercular compounds, with the first report of whole-cell antitubercular activity of bengamides P and Q .

摘要

结核病(TB)仍然是一场公共卫生危机,亟需鉴定新型抗分枝杆菌药物。我们筛选了几种海洋无脊椎动物的有机提取物和水提取物,检测其对病原体的体外抑制活性。在此,我们报告了54种海洋无脊椎动物提取物的检测结果。利用核磁共振氢谱(¹H NMR)和高分辨液相色谱-质谱联用(HR-LCMS)以及全球天然产物社会分子网络(GNPS molecular networking)对其中两种提取物的化学成分进行了去重复分析,然后对这些提取物进一步进行活性导向分离,以纯化生物活性成分。一种提取物产生了异壬内酯,另一种提取物被发现能产生苯甲酰胺类化合物,从中分离出了苯甲酰胺P和Q,同时根据其二级质谱(MS/MS)裂解模式与其他苯甲酰胺的相似性,推测鉴定出一种新衍生物苯甲酰胺S并预测了其结构。分离得到的生物活性代谢产物和半纯组分表现出抑菌活性,浓度范围为<0.24至62.50μg/mL。本研究证实苯甲酰胺类化合物是有效的抗结核化合物,首次报道了苯甲酰胺P和Q的全细胞抗结核活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8880526/74b8425aabd8/medicines-09-00009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8880526/1288c3d92731/medicines-09-00009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8880526/74b8425aabd8/medicines-09-00009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8880526/1288c3d92731/medicines-09-00009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9af8/8880526/74b8425aabd8/medicines-09-00009-g002.jpg

相似文献

1
Identification of Antimycobacterial Natural Products from a Library of Marine Invertebrate Extracts.从海洋无脊椎动物提取物文库中鉴定抗分枝杆菌天然产物。
Medicines (Basel). 2022 Jan 28;9(2):9. doi: 10.3390/medicines9020009.
2
Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis.苯并酰胺类化合物对耐药结核分枝杆菌具有很强的活性。
Sci Rep. 2019 Oct 7;9(1):14396. doi: 10.1038/s41598-019-50748-2.
3
Bengamides revisited: new structures and antitumor studies.重新审视孟加拉霉素:新结构与抗肿瘤研究
J Org Chem. 2001 Mar 9;66(5):1733-41. doi: 10.1021/jo001380+.
4
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
5
Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains.民间药用松萝(Usnea laevis Nyl.)丙酮提取物及其分离代谢产物对敏感和耐多药结核分枝杆菌的抗分枝杆菌活性。
J Ethnopharmacol. 2022 Jan 10;282:114641. doi: 10.1016/j.jep.2021.114641. Epub 2021 Sep 15.
6
Antimycobacterial activity and molecular docking of methanolic extracts and compounds of marine fungi from Saldanha and False Bays, South Africa.南非萨尔达尼亚湾和福尔斯湾海洋真菌甲醇提取物及化合物的抗分枝杆菌活性和分子对接
Heliyon. 2022 Dec 17;8(12):e12406. doi: 10.1016/j.heliyon.2022.e12406. eCollection 2022 Dec.
7
[Prospects for development of new antituberculous drugs].[新型抗结核药物的发展前景]
Kekkaku. 2002 Aug;77(8):573-84.
8
Chemical composition of Acacia farnesiana (L) wild fruits and its activity against Mycobacterium tuberculosis and dysentery bacteria.相思树野生果实的化学成分及其对结核分枝杆菌和痢疾杆菌的活性。
J Ethnopharmacol. 2019 Feb 10;230:74-80. doi: 10.1016/j.jep.2018.10.031. Epub 2018 Oct 25.
9
A Mycobacterium marinum zone of inhibition assay as a method for screening potential antimycobacterial compounds from marine extracts.一种用于从海洋提取物中筛选潜在抗分枝杆菌化合物的海鱼分枝杆菌抑菌试验方法。
Planta Med. 2007 Jun;73(6):559-63. doi: 10.1055/s-2007-981522. Epub 2007 May 30.
10
The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects.本加米德类化合物:天然来源、类似物、生物学特性、生物合成起源及未来前景的小型综述
J Nat Prod. 2017 Mar 24;80(3):740-755. doi: 10.1021/acs.jnatprod.6b00970. Epub 2017 Feb 10.

引用本文的文献

1
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges.基于片段的抗分枝杆菌药物发现:成功与挑战。
Int J Mol Sci. 2022 Sep 14;23(18):10669. doi: 10.3390/ijms231810669.
2
The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria.苯并酰胺类抗生素的研发:对抗耐药菌的新武器。
Mar Drugs. 2022 May 31;20(6):373. doi: 10.3390/md20060373.

本文引用的文献

1
Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis.苯并酰胺类化合物对耐药结核分枝杆菌具有很强的活性。
Sci Rep. 2019 Oct 7;9(1):14396. doi: 10.1038/s41598-019-50748-2.
2
Cytoscape Automation: empowering workflow-based network analysis.Cytoscape 自动化:赋能基于工作流的网络分析。
Genome Biol. 2019 Sep 2;20(1):185. doi: 10.1186/s13059-019-1758-4.
3
Marine natural products as potential anti-tubercular agents.海洋天然产物作为潜在的抗结核药物。
Eur J Med Chem. 2019 Mar 1;165:273-292. doi: 10.1016/j.ejmech.2019.01.026. Epub 2019 Jan 14.
4
NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening.NCI 天然产物发现计划:用于高通量筛选的公开天然产物馏分文库。
ACS Chem Biol. 2018 Sep 21;13(9):2484-2497. doi: 10.1021/acschembio.8b00389. Epub 2018 Jun 13.
5
The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects.本加米德类化合物:天然来源、类似物、生物学特性、生物合成起源及未来前景的小型综述
J Nat Prod. 2017 Mar 24;80(3):740-755. doi: 10.1021/acs.jnatprod.6b00970. Epub 2017 Feb 10.
6
Current perspectives in drug discovery against tuberculosis from natural products.天然产物抗结核药物研发的当前观点
Int J Mycobacteriol. 2015 Sep;4(3):165-83. doi: 10.1016/j.ijmyco.2015.05.004. Epub 2015 Jun 3.
7
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking.通过全球天然产物社会分子网络共享和社区管理质谱数据。
Nat Biotechnol. 2016 Aug 9;34(8):828-837. doi: 10.1038/nbt.3597.
8
An analysis of FDA-approved drugs: natural products and their derivatives.对美国食品药品监督管理局(FDA)批准药物的分析:天然产物及其衍生物。
Drug Discov Today. 2016 Feb;21(2):204-7. doi: 10.1016/j.drudis.2015.01.009. Epub 2015 Jan 21.
9
Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.作为一类新型抗结核药物的结核分枝杆菌gyrase抑制剂。
Antimicrob Agents Chemother. 2015 Apr;59(4):1868-75. doi: 10.1128/AAC.03913-14. Epub 2015 Jan 12.
10
Trends in discovery of new drugs for tuberculosis therapy.结核病治疗新药的发现趋势。
J Antibiot (Tokyo). 2014 Sep;67(9):655-9. doi: 10.1038/ja.2014.109. Epub 2014 Aug 6.